Viela Bio is dedicated to the development and commercialization of novel, life-changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. The team is comprised of passionate, talented, world-class leaders with diverse experience in the autoimmune disease space and our research focuses on well-established critical biological pathways shared across multiple indications. The team believe that the approach – which targets the underlying molecular pathogenesis of the disease – enables Viela Bio to develop more precise therapies, identify patients more likely to respond to treatment and pursue multiple indications for each of their product candidates.
Location: United States, Maryland, Gaithersburg
Employees: 51-200
Total raised: $600M
Founded date: 2017
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.06.2019 | Series B | $350M | - |
| 01.03.2018 | Series A | $250M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 01.02.2021 | Gaithersburg’s Viela Bio is set to be acquired for $3.05B | Gaithersburg, Maryland-based Viela Bio is set to be acquired by Dublin-based biopharmaceutical compa... | technical.... |
| 20.06.2019 | Gaithersburg-based Viela Bio closed on a $75M Series B fundi... | Gaithersburg, Md.-based Viela Bio announced that it has closed on a $75 million Series B funding rou... | technical.... |
| 18.06.2019 | Temasek backs $75m Series B for US-based Viela Bio | Premium US-based clinical-stage biotechnology company Viela Bio has raised $75 million in a Series B... | dealstreet... |
| 18.06.2019 | How Viela Bio's Drug Development Landed $350M in Funding in ... | Just 16 months into its existence, a local biotech startup has investors swarming. Gaithersburg, Md.... | bizjournal... |
| 17.06.2019 | Viela Bio Closes $75M Series B Financing | Viela Bio, a Gaithersburg, MD-based clinical-stage biotechnology company, completed a $75m in Series... | finsmes.co... |
| 17.06.2019 | Viela Bio Closes $75M Series B Financing | GAITHERSBURG, Md.--(BUSINESS WIRE)--Viela Bio today announced the successful completion of a $75 mil... | citybizlis... |
| 17.06.2019 | HBM Healthcare Investments announces investment of USD 20 mi... | Viela Bio, a privately held biotechnology company, today announced the successful completion of a US... | hbmhealthc... |
| 01.03.2018 | US biotech firm Viela Bio raises $250m in Temasek-backed Ser... | Premium US-headquartered Viela Bio, an inflammation and autoimmune biotech spinout of AstraZeneca, h... | dealstreet... |
| 01.03.2018 | Term Sheet — Thursday, March 1 | REBEL IPO Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries ... | fortune.co... |
| 28.02.2018 | Viela Bio Spins Out with Up to $250M Series A | GAITHERSBURG, MD, Viela Bio has incorporated as an independent company funded with up to $250 mill... | vcnewsdail... |
Show more